Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Amylyx Pharmaceuticals Inc., 3 years.
Amylyx Pharmaceuticals Inc.
Director
Aurinia Pharmaceuticals Inc
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 2026 | Amylyx Pharmaceuticals Inc. | Gift | −17,780 | — | — |
| Jan 24, 2025 | Amylyx Pharmaceuticals Inc. | Gift | −27,910 | — | — |
| Sep 3, 2024 | Amylyx Pharmaceuticals Inc. | Open-market purchase | +100,000 | $2.20 | $220,000 |
| Jan 25, 2024 | Amylyx Pharmaceuticals Inc. | Gift | −9,100 | — | — |
| Jan 16, 2024 | Amylyx Pharmaceuticals Inc. | Gift | −94,350 | — | — |
| May 18, 2023 | Aurinia Pharmaceuticals Inc | Option exercise | +8,733 | — | — |
| Mar 16, 2023 | Amylyx Pharmaceuticals Inc. | Open-market sale | −33,084 | $31.86 | $1,054,056 |
| Mar 16, 2023 | Amylyx Pharmaceuticals Inc. | Open-market sale | −1,916 | $32.45 | $62,174 |
| Mar 2, 2023 | Aurinia Pharmaceuticals Inc | Open-market purchase | +20,000 | $8.91 | $178,200 |
| Dec 29, 2022 | Amylyx Pharmaceuticals Inc. | Gift | −13,800 | — | — |
| Jan 6, 2022 | Amylyx Pharmaceuticals Inc. | Derivative conversion | +689,425 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.